Work

CD5 positivity and aberrant P53 expression predict primary refractoriness to first-line pola-R-CHP in patients with diffuse large B-cell lymphoma

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-1887

Authors: Xia Zhao, Zhihe Liu, Junqing Xu, Guoqiang Liu

Institutions: Affiliated Hospital of Qingdao University, Qingdao University, Yuhuangding Hospital, Shengli Oilfield Central Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417018919

Cites:

Cited by:

Related to: